US8391992B2 - Implantable medical device switching power supply including multiple modes - Google Patents
Implantable medical device switching power supply including multiple modes Download PDFInfo
- Publication number
- US8391992B2 US8391992B2 US12/956,375 US95637510A US8391992B2 US 8391992 B2 US8391992 B2 US 8391992B2 US 95637510 A US95637510 A US 95637510A US 8391992 B2 US8391992 B2 US 8391992B2
- Authority
- US
- United States
- Prior art keywords
- mode
- medical device
- implantable medical
- inductor
- magnetic field
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 230000005291 magnetic effect Effects 0.000 claims abstract description 103
- 230000001939 inductive effect Effects 0.000 claims abstract description 57
- 238000000034 method Methods 0.000 claims description 19
- 230000005294 ferromagnetic effect Effects 0.000 claims description 14
- 230000004044 response Effects 0.000 claims description 11
- 230000005355 Hall effect Effects 0.000 claims description 5
- 239000011162 core material Substances 0.000 description 59
- 238000002595 magnetic resonance imaging Methods 0.000 description 40
- 238000005481 NMR spectroscopy Methods 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 16
- 229920006395 saturated elastomer Polymers 0.000 description 16
- 230000003068 static effect Effects 0.000 description 14
- 230000005284 excitation Effects 0.000 description 13
- 230000002829 reductive effect Effects 0.000 description 12
- 239000003990 capacitor Substances 0.000 description 10
- 239000004020 conductor Substances 0.000 description 10
- 230000008859 change Effects 0.000 description 8
- 230000001276 controlling effect Effects 0.000 description 8
- 230000007423 decrease Effects 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 230000004907 flux Effects 0.000 description 6
- 239000007943 implant Substances 0.000 description 6
- 101100464782 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CMP2 gene Proteins 0.000 description 5
- 230000035699 permeability Effects 0.000 description 5
- 101100464779 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) CNA1 gene Proteins 0.000 description 4
- 230000000747 cardiac effect Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000004217 heart function Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000015654 memory Effects 0.000 description 4
- 230000005672 electromagnetic field Effects 0.000 description 3
- 238000004146 energy storage Methods 0.000 description 3
- 230000010287 polarization Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 102100032449 EGF-like repeat and discoidin I-like domain-containing protein 3 Human genes 0.000 description 2
- 101001016381 Homo sapiens EGF-like repeat and discoidin I-like domain-containing protein 3 Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 206010049447 Tachyarrhythmia Diseases 0.000 description 2
- 208000001871 Tachycardia Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 238000009125 cardiac resynchronization therapy Methods 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000003302 ferromagnetic material Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000005003 heart tissue Anatomy 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000005534 acoustic noise Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000005381 magnetic domain Effects 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 230000005415 magnetization Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000004007 neuromodulation Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000002633 shock therapy Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 229910000859 α-Fe Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
- A61N1/3718—Monitoring of or protection against external electromagnetic fields or currents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
- A61N1/3688—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions configured for switching the pacing mode, e.g. from AAI to DDD
Definitions
- Implantable medical devices can perform a variety of diagnostic or therapeutic functions.
- an IMD can include one or more cardiac function management features, such as to monitor the heart or to provide electrical stimulation to a heart or to the nervous system, such as to diagnose or treat a subject, such as one or more electrical or mechanical abnormalities of the heart.
- cardiac function management features such as to monitor the heart or to provide electrical stimulation to a heart or to the nervous system, such as to diagnose or treat a subject, such as one or more electrical or mechanical abnormalities of the heart.
- IMDs can include pacers, automatic implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, implantable monitors, neuromodulation devices (e.g., deep brain stimulators, or other neural stimulators), cochlear implants, or drug pumps, among others.
- ICDs automatic implantable cardioverter-defibrillators
- CRT cardiac resynchronization therapy
- neuromodulation devices e.g., deep brain stimulators, or other neural
- MRI Nuclear magnetic resonance imaging
- an item such as an IMD
- MR Safe if the item poses no known hazard in all MRI environments.
- MR Safe items can include non-conducting, non-metallic, non-magnetic materials, such as glass, porcelain, a non-conductive polymer, etc.
- An item can be referred to as “MR Conditional” in the MR field if the item has been demonstrated to pose no known hazards in a specified MRI environment with specified conditions of use (e.g., static magnetic field strength, spatial gradient, time-varying magnetic fields, RF fields, etc.).
- MR Conditional items can be labeled with testing results sufficient to characterize item behavior in a specified MRI environment.
- Testing can include, among other things, magnetically induced displacement or torque, heating, induced current or voltage, or one or more other factors.
- An item known to pose hazards in all MRI environments, such as a ferromagnetic scissors, can be referred to as “MR Unsafe.”
- Ambulatory or implantable medical devices can include an “MRI mode,” such as activated manually or automatically.
- the MRI mode can configure the device into an “MR Conditional” mode, such as including a non-sensing, fixed-rate pacing mode such as to maintain pacing therapy during an MRI scan.
- high-voltage tachyarrhythmia therapy e.g., defibrillation shock
- can be disabled in the MRI mode such as to prevent inappropriate shocks from being administered by the device, with the patient being closely monitored during the MRI procedure, or to prevent unwanted torques or forces being exerted on the IMD or one or more other conductive implants (e.g., a lead or sensor subsystem, separate from or attached to the IMD, etc.).
- the MRI mode may mitigate some of the hazards to a subject in or near an MR fields, such as generated by nuclear magnetic resonance (NMR) equipment (e.g., an NMR spectrometer, an MRI scanner, etc.).
- NMR nuclear magnetic resonance
- the MRI mode is not configured automatically, this mitigation can need the intervention of an external programmer and an electrophysiologist, cardiologist, or likewise skilled medical professional capable of temporarily re-programming the device into the MRI mode.
- the medical professional can then restore the device to its previous mode of operation, such as before the patient can be released.
- burden of performing an MRI procedure on a subject having an IMD can be reduced if the IMD can detect nearby NMR equipment, automatically activating MRI mode when necessary.
- an IMD can include one or more power supplies, such as one or more relatively high-efficiency switching power supplies.
- the present inventors have also recognized, among other things, that the operation of an inductive switching supply can be altered by the presence of externally-applied electromagnetic fields, such as one or more of a static, spatial gradient, or RF excitation field, such as used by NMR equipment (e.g., an MRI scanner or an NMR spectrometer, or other NMR device).
- the IMD can include an inductive switching power supply having more than one mode, such as a non-MRI mode and an MRI-mode. In the non-MRI mode, the switching supply can use an inductor with an unsaturated ferrite core.
- the switching supply can use an inductor having a saturated core or having a reduced inductance, such as by adjusting one or more power supply operating parameters including one or more of a comparator bias, a peak or minimum inductor current, or a duration of one or more of a charge phase or dump phase of operation.
- An implantable or other ambulatory medical device can include a magnetic field detector, such as configured to detect an intense magnetic field.
- the ambulatory or implantable medical device can include an inductive switching supply, such as including one or more of a peak current comparator, or a zero current comparator.
- the ambulatory or implantable medical device can include a controller circuit, configured to control a switch, such as to controllably charge an inductor included in the inductive switching supply.
- Example 1 includes subject matter (such as an apparatus) comprising an implantable medical device, including a magnetic field detector, an inductive switching supply including an inductor having a ferromagnetic core, a peak current comparator configured to compare an inductor current through the inductor to a specified peak current threshold, and a zero current comparator configured to compare the inductor current to a specified minimum inductor current threshold, a controller circuit configured to control a state of a switch using information from the peak current comparator and the zero current comparator when the implantable medical device is configured in a first mode of operation.
- the switch can be configured to controllably charge the inductor
- the controller circuit can be configured to adjust the implantable medical device to the first mode of operation in response to information provided by the magnetic field detector indicating an absence of an intense magnetic field.
- Example 2 the subject matter of Example 1 can optionally include a magnetic field detector comprising a Hall effect sensor.
- Example 3 the subject matter of one or any combination of Examples 1-2 can optionally include a magnetic field detector comprising a core saturation detector configured to detect saturation of the inductor, and the intense magnetic field, when present, is intense enough to saturate the inductor.
- a magnetic field detector comprising a core saturation detector configured to detect saturation of the inductor, and the intense magnetic field, when present, is intense enough to saturate the inductor.
- Example 4 the subject matter of one or any combination of Examples 1-3 can optionally include a controller circuit configured to adjust the implantable medical device to a second mode of operation in response to information provided by the magnetic field detector indicating a presence of the intense magnetic field.
- Example 5 the subject matter of one or any combination of Examples 1-4 can optionally include a controller circuit comprising at least one timer circuit, the controller circuit configured to control the state of the switch using at least one of a specified maximum charge phase duration, or a specified maximum dump phase duration, using the timer circuit, when the implantable medical device is configured in the second mode of operation.
- Example 6 the subject matter of one or any combination of Examples 1-5 can optionally include, in the second mode of operation, one or more of the specified maximum charge duration or the specified maximum dump phase duration made shorter than a corresponding charge phase duration or dump phase duration in the first mode operation.
- Example 7 the subject matter of one or any combination of Examples 1-6 can optionally include an error comparator configured to compare an output of the inductive switching supply to a specified output reference, and configured to provide an error signal indicative of the comparison, and a controller circuit configured to adjust one or more of the charge phase duration, or the dump phase duration, using information about the error signal, when the implantable medical device is configured in the second mode of operation.
- an error comparator configured to compare an output of the inductive switching supply to a specified output reference, and configured to provide an error signal indicative of the comparison
- a controller circuit configured to adjust one or more of the charge phase duration, or the dump phase duration, using information about the error signal, when the implantable medical device is configured in the second mode of operation.
- Example 8 the subject matter of one or any combination of Examples 1-7 can optionally include an error comparator configured to compare an output of the inductive switching supply to a specified output reference, and configured to provide an error signal indicative of the comparison, and a controller circuit configured to adjust a repetition rate of successive charge and dump phases using information about the error signal, when the implantable medical device is configured in the second mode of operation.
- an error comparator configured to compare an output of the inductive switching supply to a specified output reference, and configured to provide an error signal indicative of the comparison
- a controller circuit configured to adjust a repetition rate of successive charge and dump phases using information about the error signal, when the implantable medical device is configured in the second mode of operation.
- Example 9 the subject matter of one or any combination of Examples 1-8 can optionally include a controller circuit configured to adjust the implantable medical device back to the first mode of operation using information about the magnetic field provided by the magnetic field detector when the magnetic field detector is no longer exposed to an intense magnetic field.
- Example 10 the subject matter of one or any combination of Examples 1-9 can optionally include at least one of the peak current comparator or the zero current comparator comprising a first bias circuit used when the implantable medical device is in the first mode of a operation, and a second bias circuit used when the implantable medical device is in a second mode of operation, the second bias circuit configured to reduce a latency of at least one of the peak current comparator or the zero current comparator in the second mode of operation, as compared to the first mode of operation.
- Example 11 includes subject matter (such as an apparatus) comprising an implantable medical device, including a magnetic field detector, an inductive switching supply including an inductor including a ferromagnetic core, a peak current comparator configured to compare an inductor current through the inductor to a specified peak current threshold, a zero current comparator configured to compare the inductor current to a specified minimum inductor current threshold, a controller circuit configured to control a state of a switch using information from the peak current comparator and the zero current comparator when the implantable medical device is configured in a first mode of operation.
- an implantable medical device including a magnetic field detector, an inductive switching supply including an inductor including a ferromagnetic core, a peak current comparator configured to compare an inductor current through the inductor to a specified peak current threshold, a zero current comparator configured to compare the inductor current to a specified minimum inductor current threshold, a controller circuit configured to control a state of a switch using information from the peak current comparator and the zero current
- the switch can be configured to controllably charge the inductor, at least one of the peak current comparator or the zero current comparator includes a first bias circuit used when the implantable medical device is in the first mode of a operation, and a second bias circuit used when the implantable medical device is in the second mode of operation, the second bias circuit can be configured to reduce a latency of at least one of the peak current comparator or the zero current comparator in the second mode of operation, as compared to the first mode of operation, and the controller circuit can be configured to adjust the implantable medical device to the second mode of operation using information about a magnetic field provided by the magnetic field detector when the magnetic field detector is exposed to an intense magnetic field.
- Example 12 can include, or can optionally be combined with the subject matter of one or any combination of Examples 1-11 to include, subject matter (such as a method, a means for performing acts, or a machine-readable medium including instructions that, when performed by the machine, cause the machine to perform acts) comprising detecting a magnetic field using an implantable medical device, the implantable medical device including an inductive switching supply.
- subject matter such as a method, a means for performing acts, or a machine-readable medium including instructions that, when performed by the machine, cause the machine to perform acts
- this example in response to detecting the magnetic field, can include adjusting the implantable medical device to a first mode of operation when information about a detected magnetic field indicates an absence of an intense magnetic field, and controllably charging an inductor included as a portion of the inductive switching supply via controlling a state of a switch, in the first mode of operation, the controlling the state of the switch including using information provided by comparing an inductor current to a specified peak current threshold; and comparing the inductor current to a specified minimum inductor current threshold.
- Example 13 the subject matter of Example 12 can optionally include detecting the magnetic field including detecting saturation of the inductor, and the intense magnetic field, when present, is intense enough to saturate the inductor.
- Example 14 the subject matter of one or any combination of Examples 12-13 can optionally include adjusting the implantable medical device to a second mode of operation when information about the detected magnetic field indicates a presence of an intense magnetic field.
- Example 15 the subject matter of one or any combination of Examples 12-14 can optionally include controlling the state of the switch, in the second mode of operation, using at least one of a specified maximum charge phase duration, or a specified maximum dump phase duration.
- Example 16 the subject matter of one or any combination of Examples 12-15 can optionally include, in the second mode of operation, one or more of the specified maximum charge duration or the specified maximum dump phase duration made shorter than a corresponding charge phase duration or dump phase duration in the first mode operation.
- Example 17 the subject matter of one or any combination of Examples 12-16 can optionally include controlling the state of the switch, in the second mode of operation, including comparing an output of the inductive switching supply to a specified output reference to provide an error signal indicative of the comparison and in response, adjusting one or more of the charge phase duration, or the dump phase during using information about the error signal.
- Example 18 the subject matter of one or any combination of Examples 12-17 can optionally include controlling the state of the switch, in the second mode of operation, includes comparing an output of the inductive switching supply to a specified output reference to provide an error signal indicative of the comparison, and in response, adjusting a repetition rate of successive charge and dump phases using information about the error signal.
- Example 19 the subject matter of one or any combination of Examples 12-18 can optionally include adjusting the implantable medical device back to the first mode of operation when information about the detected magnetic field indicates the implantable medical device is no longer exposed to an intense magnetic field.
- Example 20 the subject matter of one or any combination of Examples 12-19 can optionally include at least one of the comparing an inductor current to a specified peak current threshold or comparing the inductor current to a specified minimum inductor current threshold including using a first bias circuit when the implantable medical device is in the first mode of operation, and using a second bias circuit when the implantable medical device is in a second mode of operation, the second bias circuit is configured to reduce a latency of the comparing, in the second mode of operation, as compared to the first mode of operation.
- FIG. 1 illustrates generally an example of portions of a system that can include an ambulatory or implantable medical device (IMD), such as cardiac function management device.
- IMD implantable medical device
- FIG. 2 illustrates generally an example of a boost configuration inductive switching supply, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- FIG. 3 illustrates generally an example of a buck configuration inductive switching supply, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- FIG. 4 illustrates generally an example of a buck-boost configuration inductive switching supply, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- FIG. 5 illustrates generally an example of a feedback control system for an inductive switching supply, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- FIG. 6 illustrates generally an example of a buck configuration inductive switching supply operating in a current-limited control mode, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- FIG. 7 illustrates generally an example of a boost configuration inductive switching supply operating in a current-limited control mode, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- FIG. 8 illustrates generally an example of a buck-boost configuration inductive switching supply operating in a current-limited control mode, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- FIG. 9 illustrates generally an example of components for measuring inductor current in order to detect core saturation, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- FIG. 10 illustrates plots of an example of an unsaturated inductor current, i normal (t), such as compared to a saturated inductor current, i sat (t), such as including a specified minimum duration of a charge phase.
- FIG. 11 illustrates plots of an example of an unsaturated inductor current, i normal (t), such as compared to a saturated inductor current, i sat (t), such as including one or more of specified charge phase or dump phase durations, or specified charge phase or dump phase current limits.
- Nuclear magnetic resonance (NMR) devices can produce both static and time-varying magnetic fields.
- an MRI scanner can provide a strong static magnetic field, B 0 , such as to align nuclei within a subject to the axis of the B 0 field.
- the B 0 can provide a slight net magnetization (e.g., a “spin polarization”) among the nuclei in bulk because the spin states of the nuclei are not randomly distributed among the possible spin states.
- a stronger B 0 field can be used to spin polarize the subject's nuclei to obtain finer resolution images.
- NMR devices can be classified according the magnitude of the B 0 field used during imaging, such as a 1.5 Tesla B 0 field, a 3.0 Tesla B 0 field, etc.
- one or more radio frequency (RF) magnetic excitation pulses can be delivered such as to alter the alignment of specified nuclei (e.g., within a particular volume or plane to be imaged within the subject).
- the power, phase, and range of frequencies of the one or more RF excitation pulses can be selected, such as depending on the magnitude of the B 0 field, the type or resonant frequency of the nuclei to be imaged, or one or more other factors.
- one or more RF receivers can be used to detect a time-varying magnetic field (e.g., a flux) developed by the nuclei as they relax back to a lower energy state, such as the spin polarized state induced by the static magnetic field, B 0 .
- a time-varying magnetic field e.g., a flux
- One or more gradient magnetic fields can also be provided during MR, such as to create a slight position-dependent variation in the static polarization field.
- the variation in the static polarization field slightly alters the resonant frequency of the relaxing nuclei, such as during relaxation after excitation by the one or more RF pulses.
- Using the gradient field along with the static field can provide “spatial localization” of signals detected by the RF receiver, such as by using frequency discrimination.
- Using a gradient field allows a volume or plane to be imaged more efficiently.
- signals received from relaxing nuclei can include energy in respective unique frequency ranges corresponding to the respective locations of the nuclei.
- Active MRI equipment can induce unwanted torques, forces, or heating in an IMD or other conductive implant, or can interfere with operation of the IMD.
- the interference can include disruption in sensing by the IMD, interference in communication between the IMD and other implants or external modules during MRI operation, or disruption in monitoring or therapeutic function of the IMD.
- the one or more RF excitation pulses can include energy delivered at frequencies from less than 10 MHz to more than 100 MHz, such as corresponding to the nuclear magnetic resonances of the subject nuclei to be imaged.
- the gradient magnetic field can include energy delivered at frequencies lower than the RF excitation pulses, because most of the AC energy included in the gradient field is provided when the gradient field is ramping or “slewing.”
- the one or more gradient magnetic fields can be provided in multiple axes, such as including individual time-varying gradient fields provided in each of the axes to provide imaging in multiple dimensions.
- the static field, B 0 can induce unwanted forces or torques on ferromagnetic materials, such as steel or nickel.
- the forces or torques can occur even when the materials are not directly within the “bore” of the MRI equipment—because significant fields can exist near the MRI equipment.
- an electric current is switched on or off in the presence of the B 0 field, a significant torque or force can be suddenly imposed in the plane of the circulation of the current, even though the B 0 field itself is static.
- the induced force or torque can be minimal for small currents, but the torque can be significant for larger currents, such as those delivered during defibrillation shock therapy.
- the torque can be proportional to the magnitude of the B 0 field, multiplied by the surface area of the current loop, multiplied by the current.
- Time-varying fields such as the gradient field or the field associated with the RF excitation pulse, can present different risks than the static field, B 0 .
- the behavior of a wire loop in the presence of a time-varying magnetic field can be described using Faraday's law, which can be represented by
- ⁇ - d ⁇ B 1 d t , in which ⁇ can represent the electromotive force (e.g., in volts), such as developed by a time-varying magnetic flux.
- the magnetic flux can be represented as
- Operating MRI equipment can produce a time-varying gradient field having a slew rates in excess of 100 Tesla per second (T/s). The slew rate can be similar to a “slope” of the gradient field, and is thus similar to
- EMF electromotive force
- the electromotive force (EMF) of Faraday's law can cause an unwanted heating effect in a conductor—regardless of whether the conductor is ferromagnetic.
- EMF can induce current flow in a conductor (e.g., a housing of the IMD, one or more other conductive regions within the IMD, or one or more other conductive implants).
- the induced current can dissipate energy and can oppose the direction of the change of the externally applied field (e.g., given by Lenz's law).
- the induced current tends to curl away from its initial direction, forming an “eddy current” over the surface of the conductor, such as due to Lorentz forces acting upon electrons moving through the conductor.
- the flow of induced current through the conductor can dissipate heat.
- the induced heat can cause a significant temperature rise in or near the conductor over the duration of the scan.
- the power dissipated by the eddy current can be proportional to the square of both the peak flux density and the frequency of the excitation.
- induced currents such as induced by the RF magnetic excitation pulse
- the skin effect can limit both the magnitude and depth of the induced current, thus reducing power dissipation.
- the gradient field can include energy at a much lower frequency than the RF magnetic excitation field, which can more easily penetrate through the housing of the IMD.
- the gradient field can more easily induce bulk eddy currents in one or more conductors within the IMD housing, such as within one or more circuits, capacitors, batteries, or other conductors.
- the EMF can create, among other things, non-physiologic voltages that can cause erroneous sensing of cardiac electrical activity, or the EMF can create a voltage sufficient to depolarize cardiac tissue or render the cardiac tissue refractory, possibly affecting pacing therapy.
- the IMD can be connected to one or more leads, such as one or more subcutaneous or intravascular leads positioned to monitor the patient, or to provide one or more therapies to the patient.
- a surface area of a “circuit” including the lead, the housing of the IMD, and a path through at least partially conductive body tissue between an electrode on the lead and the IMD housing can be more than 300 square centimeters, or more than 0.03 square meters.
- EMF electromotive force
- the IMD can include one or more power supplies, such as one or more relatively high-efficiency switching power supplies.
- the present inventors have also recognized, among other things, that the operation of an inductive switching supply can be altered by the presence of externally-applied electromagnetic fields, such as one or more of the static, the spatial gradient, or the RF magnetic excitation field, such as used by the NMR equipment.
- the IMD can include an inductive switching power supply having more than one mode, such as a first mode (e.g., a non-MRI mode) and a second mode (e.g., an MRI-mode).
- a first mode e.g., a non-MRI mode
- a second mode e.g., an MRI-mode
- the switching supply can use an inductor with an unsaturated ferromagnetic core.
- the switching supply can use an inductor with a saturated core or with a reduced inductor value, such as by adjusting one or more operating parameters including one or more of a comparator bias, a peak or minimum inductor current, or a duration of one or more of a charge phase or dump phase of operation, or another parameter.
- an inductor such as included in the power supply of the IMD, can be constructed with a ferromagnetic core in order to increase inductance.
- the inductance of the inductor can be effectively multiplied by the core permeability.
- an intense magnetic field such as the static field used by NMR equipment, the ferromagnetic core can saturate, which can dramatically lower the inductance.
- Such an intense magnetic field can be on the order of 1 Tesla or more, or another magnetic field intensity, such as intense enough to saturate the inductor or otherwise interfere with operation of the power supply, or one or more other IMD circuits.
- the IMD can include a magnetic detector, such as a core saturation detector, such as to detect a loss of inductance in the power inductor.
- a magnetic detector such as a core saturation detector, such as to detect a loss of inductance in the power inductor.
- one or more operating parameters of the inductive supply can be adjusted, such as in response to a detected magnetic field.
- FIG. 1 illustrates generally an example of portions of a system that can include an ambulatory or implantable medical device (IMD) 100 , such as cardiac function management device.
- a sensing circuit 101 can receive signals indicative of cardiac electrical activity (e.g., cardiac electrogram information), such as from subcutaneous or intravascular electrodes, such as implanted in the heart.
- a therapy circuit 102 can include a pulse generation circuit, such as for generating one or more pacing pulses or defibrillation shocks, or other electrostimulation therapy signals, such as to be delivered to the heart via the electrodes.
- a control circuit 103 can interpret the electrogram signals, such as to control the output of electrical stimulation to heart as needed in accordance with a normal operating mode.
- the power supply for the device 100 can include a battery 104 and one or more inductive switching supplies, such as an inductive switching supply 105 .
- the inductive switching supply 105 can be a DC-DC converter, such as configured to provide a specified regulated output voltage range V out to the electronic circuitry of the device 100 , such as to power one or more of the sensing, therapy, or control circuitries, or one or more other circuits or portions of the device 100 .
- a core saturation detector 106 can monitor one or more parameters of operation of the switching supply, such as one or more parameters that can vary as the inductance of the power inductor changes. For example, when a strong magnetic field is present, such as produced by an NMR device, the core of the power inductor can saturate, such as causing the inductance of the inductor to decrease. The resulting decrease in inductance can then be detected by the core saturation detector 106 , such as to allow the device 100 to modify its operation.
- the device upon detection of core saturation, can be configured to enter an MRI mode that can include, among other things, switching to a non-sensing fixed-rate bradycardia pacing mode (e.g., VOO), disabling of a tachyarrhythmia therapy, or adjusting or varying one or more other operating parameters such as to place the IMD in a conditionally safe mode to preserve operation in an environment including intense electromagnetic fields.
- a non-sensing fixed-rate bradycardia pacing mode e.g., VOO
- disabling of a tachyarrhythmia therapy adjusting or varying one or more other operating parameters such as to place the IMD in a conditionally safe mode to preserve operation in an environment including intense electromagnetic fields.
- the device 100 can be configured to automatically exit the MRI mode, such as when one or more electromagnetic sensors, such as a magnetic detector, (e.g., a Hall effect sensor, or the core saturation detector), indicate that the intense magnetic field is no longer present.
- the core saturation detector 106 can measure the time duration of one or more phases of the supply's power conversion cycle, such duration which can depend upon the inductance of the power inductor, such as when the supply is operating in a current-limiting mode. In an example, the core saturation detector 106 can measure the peak power inductor current in inductive supplies operating in other modes.
- the control circuitry and core saturation detector may be implemented by discrete component circuitry or a microprocessor-based controller, such as executing coded instructions stored in a memory circuit or other processor-readable medium.
- FIG. 2 illustrates generally an example of an inductive switching supply having a boost configuration, such as included in an ambulatory or implantable medical device (IMD).
- An inductive switching supply can include one or more inductors, such as including a ferromagnetic core.
- the ferromagnetic core can increase an inductance as compared to an inductor with about the same number of wire turns wound around an air core (or another non-ferromagnetic material).
- the introduction of the ferromagnetic core material can increase the inductance, such as by a factor such as representing the relative magnetic permeability of the inductor core material.
- the effective inductance value of the inductor can drop dramatically (e.g., the relative magnetic permeability of the core material, can drop to around 1.0).
- the saturation or decrease in inductance of the inductor can alter the efficiency or operating characteristics of the inductive switching supply.
- the inductive switching supply can alternately store and discharge energy, such as using an inductor, in a two-phase power conversion cycle.
- the power conversion phases can be designated as fill (e.g., charge) and dump (e.g., discharge) phases, respectively.
- Inductive switching supplies can be configured in a variety of topologies.
- three different inductive switching supply topologies can include: buck (e.g., step-down), boost (e.g., step-up), or buck-boost (e.g., inverting, having an input voltage magnitude lower or higher than the output voltage magnitude).
- the inductive energy storage element need not be a single-winding inductor.
- the inductive switching supply can include a transformer as the inductive element, and the term inductor can be used to describe many different energy storage circuits, such as used to store energy magnetically, such as including a reactor, an inductor, a transformer, or the like.
- an inductive switching supply having a boost configuration is shown.
- the switch SW 1 can close, and the input voltage V in can be impressed across an inductor L 1 .
- a diode D 1 can prevent a capacitor C 1 from discharging to ground.
- the current through the inductor L 1 can increase with time, such as at a rate that proportional to the input voltage divided by the inductance of the inductor L 1 .
- the energy stored in the inductor during the fill phase can be about equal to one-half the inductance times the square of the peak current.
- switch SW 1 can be opened after the charge phase, such as during the dump phase.
- the voltage across the inductor L 1 adjusts to maintain continued current flow, such as because the inductor current cannot change instantaneously.
- the inductor voltage can change enough to forward-bias the diode D 1 .
- the switch SW 1 can be repeatedly opened and closed, such as to produce a sequence of power conversion cycles, and the voltage V out across the capacitor C 1 can rise with every cycle as the capacitor is charged by the inductor current.
- FIG. 3 illustrates generally an example of a buck configuration inductive switching supply, such as included in an ambulatory or implantable medical device (IMD).
- circuitry such as described in FIG. 2
- the switch SW 1 can close during the fill phase, and a voltage represented by (V in ⁇ V out ) can be impressed across the inductor L 1 , such as causing the inductor current to increase.
- the inductor current can charge an output capacitor C 1 , during the fill phase.
- the switch SW 1 can open to start the dump phase, such as causing the voltage across the inductor L 1 to adjust itself to maintain current flow, which then charges the output capacitor C 1 through the diode D 1 .
- FIG. 4 illustrates generally an example of a buck-boost configuration inductive switching supply, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- locations of the inductor and diode in the circuit of FIG. 3 can be swapped, such as to provide the inverting or buck-boost configuration of the example of FIG. 4 .
- V in is impressed across the inductor, making the inductor current ramp up.
- the switch opens to start the dump phase the current flow is maintained by the voltage across the inductor.
- the inductor current during the dump phase can then flow through the diode and can charge the output capacitor to an output voltage V out , such as having the opposite polarity as the input voltage V in .
- FIG. 5 illustrates generally an example of a feedback control system for an inductive switching supply, such as included in an ambulatory or implantable medical device (IMD).
- a feedback control system may be used to regulate the output voltage V out in any of the examples of FIGS. 2-4 , such as by controlling the switch SW 1 using information about an error signal.
- FIG. 5 includes a comparator 206 that can compare the instantaneous output voltage V out with a reference voltage V ref , such as to generate an error signal ERR.
- the error signal ERR can be provided to a feedback controller 210 .
- the controller 210 can control the state of the switch SW 1 , such as to reduce the error signal.
- the feedback controller can be configured to operate using various control laws or modes. For example, in a clocked frequency modulation control mode, the feedback controller can gate an oscillator to operate the switch SW 1 and generate power conversion cycles, such as to reduce the error signal ERR, such as controlling a pulse repetition rate or frequency of switching control pulses (e.g., increasing or decreasing a number of successive fixed pulse-width signals over a specified duration such as to cycle SW 1 more or less often during the specified duration).
- a pulse repetition rate or frequency of switching control pulses e.g., increasing or decreasing a number of successive fixed pulse-width signals over a specified duration such as to cycle SW 1 more or less often during the specified duration.
- the feedback controller 210 can control the switch SW 1 to generate power conversion cycles, such as to reduce the error signal ERR, such as by controlling durations of the fill and dump phases using information about the inductor current.
- the switch SW 1 can be operated so that the inductor current increases during the fill phase until a specified peak current value is reached and then decreases during the dump phase to zero or some other predetermined value.
- the feedback controller in an on-demand current-limited control mode, can inhibit power conversion cycles when the output voltage is at or above a specified output voltage, and the feedback controller can trigger or begin one or more conversion cycles, such as when the output voltage falls below the specified output voltage.
- the feedback controller operates the switch SW 1 at a fixed frequency but varies the durations of the fill and dump phases to decrease the error signal (i.e., increases the duration of the fill phase to increase the output voltage and vice-versa).
- FIG. 6-8 illustrate generally respective examples of a buck configuration inductive switching supply, a boost configuration inductive switching supply, and a buck-boost configuration inductive switching supply, each respectively operable in a current-limited control mode, or one or more other modes or according to one or more other specified control laws, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- inductor As discussed above, exposure to an intense magnetic field can saturate an inductor's ferromagnetic core, or can dramatically reduce the inductance of the inductor. Thus, reduced inductance can allow a much higher rate of change in inductor current during each power conversion phase. In a switching supply, such as operating in a current-limited pulse frequency modulated control mode this can cause the fill and dump phases to occur more frequently, with each having a shorter respective duration, and the energy delivered to the load per power conversion cycle can be much lower as the energy storage of an inductor can be represented by: 0.5*L*I 2 .
- the peak inductor current during a power conversion cycle can increase dramatically as the inductance decreases, such as due to exposure to the intense magnetic field.
- An inductive switching supply operating in a current-limited control mode can be configured to generate, among others, three signals such as indicating the start and end of the power conversion phases, such as for use by the core saturation detector of FIG. 1 .
- FPS e.g., “Fill Phase Start”
- PKIC e.g., “Peak Inductor Current”
- ZIC e.g., “Zero Inductor Current”
- the core saturation detector 106 can measure the length of the fill or dump phase, such as using information about the time intervals between FPS and PKIC or between PKIC and ZIC, respectively.
- the inductive switching supply circuits can operate using a current-limited frequency control mode in buck, boost, and buck-boost configurations, respectively.
- the examples of FIGS. 6-8 can each include one or more of a respective inductor L 1 , a respective switch SW 1 , a respective capacitor C 1 , and a respective diode D 1 .
- a current-limited control mode e.g., either synchronously, such as trigged by or using one or more clocks or timers, or asynchronously
- the duration of the fill and dump phases during a power-conversion cycle can be controlled, such as via feedback from an inductor L 1 current monitor.
- the inductor current can be near zero and can ramps upwards, such as towards a specified peak current value.
- the fill phase can be terminated and, for example, a dump phase can begin.
- the inductor L 1 current can be around the specified peak current value, and can ramp back down towards zero.
- the dump phase can be terminated.
- further successive fill-dump cycles can be initiated or suppressed, such as by using feedback.
- the feedback can include sensing one or more of an output current or voltage, and comparing the output current or voltage with a reference, such as to provide an error signal.
- a MOS switch SW 1 can be controlled by the output of a flip-flop FF 1 , such as to switch a battery (or other input) voltage V + across inductor L 1 and capacitor C 1 .
- the capacitor C 1 voltage can be the output voltage V o of the supply.
- the switch SW 1 closes, the fill phase can begin, and the inductor current can increase, such as providing a roughly constant voltage across the inductor L 1 .
- the switch SW 1 opens the fill phase can end and the dump phase can begin.
- the voltage across the inductor L 1 can reverse polarity, such as to maintain the flow of inductor current (because the inductor current cannot change instantaneously).
- the current through the inductor L 1 can flow through diode D 1 , and can decrease, such as assuming a roughly constant voltage across the inductor.
- the durations of the fill and dump phases can be controlled by circuitry, such as using information about the inductor current. For example, a portion of the output voltage V o can be fed back, such as via a voltage divider made up of resistors R a and R b , such as to a comparator CMP 1 . In an example, the fed back voltage can be compared, such as to a reference voltage V ref1 . In an example, if the output voltage is low, the output of CMP 1 can be asserted, and a power conversion cycle can be triggered. The inductor L 1 current can be measured, such as using current sense resistors R 1 a or R 1 b . In an example, the voltage across current sense resistors R 1 a or R 1 b can be fed to respective comparators CMP 2 or CMP 3 .
- the inverted output of comparator CMP 3 can be asserted when the inductor current is zero, such as indicated by the assertion of an AND gate G 2 , such as to provide the signal ZIC.
- comparator CMP 3 can have a small negative input offset voltage, such as to ensure that the ZIC signal is asserted when the inductor current is zero.
- a delay element DEL 1 and the AND gate G 2 can gate the output of comparator CMP 3 , such as to ensure that the signal ZIC is only used when the output of comparator CMP 3 is valid.
- the AND gate G 2 , the comparator CMP 3 , and the delay element DEL 1 can be used as a zero current detector circuit. For example, the rising edge of signal ZIC can indicate that the previous dump cycle has ended, such as because the inductor current has decreased to about zero.
- the outputs of the gate G 2 and the comparator CMP 1 can be ANDed together, such as using an AND gate G 1 , such as to provide the FPS signal, such as to trigger the fill phase, such as by setting a flip-flop FF 1 .
- the flip-flop FF 1 can include an output that can be used to control the state of switch SW 1 .
- the fill phase can continue, such as until the inductor current, which flows through sense resistor R 1 a during the fill phase, reaches a specified peak value.
- the voltage across resistor R 1 a can be compared to a voltage, such as derived from a reference current I ref1 , such as using a comparator CMP 2 .
- the reference current I ref1 can run through a resistor Rc.
- the values of the reference current I ref1 or the resistor Rc can be specified, such as to provide the output PKIC from comparator CMP 2 when the inductor current reaches or exceeds the specified peak value.
- the comparator CMP 2 , and the resistors R 1 a and Rc can be used as a peak current detector circuit.
- the assertion of PKIC can be used to reset the flip-flop FF 1 , such as to indicate the end of the fill phase and the beginning of the dump phase.
- components similar to FIG. 6 can be included, such as to provide respective inductive switching supplies in boost and buck-boost configurations, respectively, the operations of which can be similar to that of the buck configuration of FIG. 6 .
- a start of the fill phase, an end of the fill phase, or an end of the dump phase can be respectively controlled or indicated, such as by assertions of the FPS, PKIC, or ZIC signals, respectively, or using one or more other signals.
- a current sense resistor R 1 and an AND gate G 1 can be used to implement the inductor current monitor circuit.
- the length of the fill phase can be measured, and can be compared to a threshold value, such as to determine if core saturation exists, or to determine if the inductor L 1 inductance is decreasing dramatically.
- a threshold value such as to determine if core saturation exists, or to determine if the inductor L 1 inductance is decreasing dramatically.
- the battery or input voltage can be impressed across the inductor L 1 during the fill phase. If the battery voltage does not change significantly during the fill phase of an individual charging cycle, then the inductor current can exhibit a fairly constant rate of change (dI/dt) during the fill phase. That is, the inductor current can change roughly linearly if the voltage across the inductor is roughly constant.
- L can be reduced by a factor of about ⁇ m , (e.g., the relative magnetic permeability of the core material).
- ⁇ m e.g., the relative magnetic permeability of the core material
- the length of the dump phase can be measured and compared, such as to a threshold value, such as to determine if core saturation exists or to determine if the inductor L 1 inductance is decreasing dramatically.
- a threshold value such as to determine if core saturation exists or to determine if the inductor L 1 inductance is decreasing dramatically.
- the output voltage can be impressed across the inductor L 1 , such as during the dump phase (such as neglecting the forward bias voltage of the diode D 1 ).
- L when the inductor core saturates, L can be reduced, such as by a factor of ⁇ m (the relatively magnetic permeability of the core material).
- ⁇ m the relatively magnetic permeability of the core material
- the core saturation detector 106 can be used to measure the length of the fill phase t fill , such as using information about the time interval between the assertions of the FPS signal and the PKIC signal, or one or more other signals.
- the dump phase t dump can be determined, such as using information about the time interval between the assertions of PKIC and ZIC, or the total power conversion cycle time as the time interval between the assertions of FPS and ZIC, or using one or more other signals.
- the core saturation detector can compare one or more measured time intervals to one or more specified threshold values, such as to determine if core saturation exists. In an example, one or more portions or parts of the comparison can be implemented programmatically, or such as using one or more circuits.
- the core saturation detector can include one or more timers, counters, or delay elements, such as to establish one or more minimum allowable time intervals between starting and stopping events (e.g., a minimum fill phase duration, a minimum dump phase duration, or one or more intervals).
- the core saturation detector can include a counter, such as is started or reset by one phase signal and stopped by another phase signal (e.g., started and reset by FPS and stopped by PKIC, such as to measure the fill phase duration).
- the counter's value can be compared to a specified threshold value. In an example, if the counter's value is at or above the threshold, a bit can be set, such as readable by the controller, such as to indicate core saturation.
- the diode D 1 (e.g., a “catch diode” or “commutating diode”) can be replaced with a switch or other device (e.g., one or more transistors), such as to provide a controllable or switchable connection, such as controllable by voltage or current feedback as discussed in FIGS. 5-8 .
- D 1 can be replaced with a switch controlled by a logical inverse of the zero inductor current (ZIC) signal.
- ZIC zero inductor current
- D 1 can be replaced with a switch controlled by a signal such as provided by a logical NOR of the FF 1 Q output and the ZIC signal.
- FIG. 9 illustrates generally an example of components for measuring inductor current in order to detect core saturation, such as included in an ambulatory or implantable medical device (IMD).
- IMD implantable medical device
- the peak inductor current during a power conversion cycle can increase drastically if the inductor core saturates.
- the current through the inductor in any of the buck, boost, or inverting configurations can be measured and compared with a specified threshold value.
- the specified threshold can be set to value well above any inductor current value expected to occur under normal operating conditions.
- the inductor current can be measured such as using similar components or techniques to those used to measure inductor current for the current-limited control modes such as included in the examples of FIGS. 6-8 .
- FIG. 9 includes an example in which the voltage across a current sense resistor R 1 c can be fed to a comparator CMP 9 , such as when the voltage is approximately equal to R 1 c *I L , where I L can represent the inductor current.
- a specified limit value V limit such as corresponding to an inductor current above the specified threshold value, core saturation can be declared as detected.
- the output of the comparator CMP 9 can be used to set a bit readable by the controller.
- FIG. 10 illustrates plots of an example of an unsaturated inductor current, i normal (t) as compared to a saturated inductor current, i sat (t), such as including a specified minimum duration of a charge phase (e.g., fill phase), t min , such as for one or more of the inductive switching supply topologies such as shown in FIGS. 2-8 .
- a switching supply may fail to deliver adequate performance unless steps are taken to compensate for the temporary loss in inductance.
- the switching supply may drain such significant current, such as from a battery, such as causing the battery voltage to temporarily or permanently decline to a value insufficient to sustain operation of the ambulatory or implantable medical device (e.g., falling below a “reset” threshold, triggering an end-of-device-life indicator, etc.).
- the device can be configured to alter the operation of switching supply, such as by increasing inductor peak current in a current-limited control mode, increasing pulse width in a clocked frequency modulation control mode, entering a power-saving mode in order to reduce the load, or by one or more other contingencies.
- an implantable medical device can include one or more supplies, such as the buck-boost (e.g., inverting) supply of FIG. 8 , and during normal operation, the supply can use a peak inductor current threshold of 12 mA when in a buck mode, and a peak inductor current threshold of 36 mA when in a boost mode.
- the supply when inductor saturation is detected, can use a peak inductor current threshold of 36 mA regardless of whether the supply is in buck or boost mode, such as to at least partially compensate for reduced inductance of the power storage inductor.
- an ambulatory or implantable device can be configured to enter or revert to its normal operating mode (e.g., a first operating mode) when core saturation is no longer detected (e.g., using information from one or more magnetic field detectors such as the core saturation detector discussed above, a Hall effect sensor, a voltage sensor, or one or more other sensors configured to detect an intense magnetic field), such as after entering (e.g., manually or automatically) a conditional MRI mode.
- one or more criteria can be used, such as by the controller of FIG.
- the IMD operating mode such as including time delay from de-assertion of the core saturation detector or Hall sensor, subsidence or reduction of coupled noise induced by the field in one or cardiac electrical activity sensors, subsidence of mechanical vibration or acoustic noise induced in the IMD or coupled to the IMD, such as due to the MRI spatial gradient fields, or using one or more other criteria or sensors.
- the saturated inductor current i sat (t) can reach the normal specified peak current i p much more rapidly than during unsaturated operation.
- one or more comparators such as the comparator CMP 3 as shown in FIGS. 6-8 , can use biasing conditions to detect i normal (t) crossing the specified peak current threshold i p , with a specified latency (e.g., such as specified to limit overshoot of the normal inductor current).
- the present inventors have recognized, among other things, that the latency between the saturated inductor current i sat (t) crossing the specified peak current threshold i p , and the assertion of the PKIC signal can result in significant overshoot of the inductor current, such as to a peak current i satp well beyond the desired specified peak current i p .
- One approach to respond to comparator latency is to leave the bias conditions of the one or more comparators unchanged, and to limit the minimum charging phase duration, such as to a minimum duration t min , such as 1 ⁇ s, as discussed above in the illustrative examples.
- the peak current comparison can be ignored when the inductor current crosses the specified peak current threshold at a time before the minimum charging phase duration.
- this approach can have disadvantages. For instance, the peak inductor current i satp can be relatively uncontrolled.
- the peak current may be sufficient to cause substantial voltage droop of the voltage input. Such voltage droop can upset other supplies or circuitry, such as in included in the ambulatory or implantable medical device.
- the one or more comparators used to detect zero inductor current can also have a latency between an actual zero-crossing by the saturated inductor current, i sat (t), and assertion of the ZIC signal.
- the present inventors have also recognized, among other things, that a delay in assertion of the ZIC signal (e.g., a delay in detecting a zero-crossing of the inductor current) can result in a significant negative saturated inductor current, i error , such as during the dump phase of operation. Negative inductor current can be undesirable because the negative current effectively drains energy back out of the storage inductor without performing useful work (e.g., the current is not supplied to the load), eroding efficiency.
- the total energy delivered to the load per fill-dump cycle becomes even more limited, potentially preventing the supply from maintaining the output voltage within a specified range (e.g., the supply can fail to meet the energy demand of the load).
- FIG. 11 illustrates plots of an example of an unsaturated inductor current i normal (t), as compared to a saturated inductor current, i sat (t), such as including one or more of a specified charge phase duration, t chg , a specified dump phase durations, t dmp , a specified charge phase saturated inductor current limit, i satp , or a specified dump phase saturated inductor current limits, i satmin .
- one or more of the switching supplies of FIGS. 2-8 can be operated in a first mode during ambulatory operation, when an intense magnetic field is not present or detected, or when the device (e.g., device 100 of FIG. 1 ) is programmed to a non-MRI mode. Then, when the device is programmed to an MRI-mode, or such as when an intense magnetic field is detected, the one or more switching supplied of FIGS. 2-8 can be operated in a second mode, such as over the duration of exposure to the intense magnetic field.
- the one or more switching supplies of FIGS. 2-8 can be operated using the current-limited pulse frequency modulation control mode during normal ambulatory operation, and using the clocked pulse frequency modulation mode when exposed to the intense magnetic field.
- the flip-flop FF 1 of the examples of FIGS. 6-8 can be replaced or switched to operating as a D-type flip-flop, such as using a clocked data signal provided by the controller of FIG. 1 , such as to provide synchronous charge and dump phases, such as triggered using information from a comparator such as CMP 1 , as shown in FIGS. 6-8 .
- the supply can operate an a pulse-frequency modulation mode such as using one or more of the specified charge phase duration or the specified dump phase duration, t chg , or t dmp , respectively.
- the supply can operate in a combination pulse-frequency or pulse-width modulation mode, such as by modifying one or more of the specified charge phase duration or the specified dump phase duration, t chg , or t dmp , respectively, but while still limiting the maximum dump-phase duration, such as to avoid negative inductor current. For example, if an error signal indicates significant output voltage error, one or more of the t chg , or t dmp intervals can be extended, up to their respective specified maximum values. Then, in this example, a pulse repetition rate can be increased (providing more charge-dump cycles per unit time), such as to maintain output voltage to a constant load.
- the supply can operate in a current-limited control mode, such as using one or more modified biasing conditions for one or more of the peak current detection circuit, or the zero current detection circuit.
- a current-limited control mode such as using one or more modified biasing conditions for one or more of the peak current detection circuit, or the zero current detection circuit.
- CMP 2 or CMP 3 such as shown in FIGS. 6-8 can include at least two controllable bias conditions, such as provided by a first bias circuit or a second bias circuit.
- the one or more comparators can be configured for current detection when the inductor current is similar to i normal (t) (e.g., when the inductor is unsaturated or has a normal inductance).
- the first bias condition can be used in the normal or ambulatory mode of operation (e.g., the first mode), such as to provide reduced comparator power consumption, as compared to a second bias condition.
- the second bias condition such as using the second bias circuit, can include bias parameters or circuitry for higher-speed comparator operation (e.g. the second mode), such as when the one or more comparators are used for current detection when the inductor current is similar to i sat (t).
- the higher-speed comparator operation can be used when the ambulatory or implantable medical device is exposed to an intense magnetic field, such as manually configured to the second mode, or automatically configured to the second mode (e.g., using a magnetic field detector such as a core saturation detector, a Hall effect sensor, or the like).
- the second bias condition can cause the one or more comparators to consume more power in the second mode than in the first mode.
- the overall battery life (e.g., longevity) of the ambulatory or implantable medical device need not be significantly reduced since the second mode of operation is used only temporarily, such as during exposure to an intense magnetic field.
- the latency of the one or more comparators can be reduced, such as to limit one or more of peak or minimum inductor current overshoot, such as using the second bias condition, and thus the supply can terminate a charge phase (e.g., a fill phase) when the saturated inductor current reaches a specified peak current, i satp , or the supply can terminate a dump phase when the saturated inductor current reaches a specified minimum inductor current, i satmin , such as around or slightly above zero current.
- a charge phase e.g., a fill phase
- i satp a specified peak current
- i satmin a specified minimum inductor current
- the terms “a” or “an” are used, as is common in patent documents, to include one or more than one, independent of any other instances or usages of “at least one” or “one or more.”
- the term “or” is used to refer to a nonexclusive or, such that “A or B” includes “A but not B,” “B but not A,” and “A and B,” unless otherwise indicated.
- Method examples described herein can be machine or computer-implemented at least in part. Some examples can include a computer-readable medium or machine-readable medium encoded with instructions operable to configure an electronic device to perform methods as described in the above examples.
- An implementation of such methods can include code, such as microcode, assembly language code, a higher-level language code, or the like. Such code can include computer readable instructions for performing various methods. The code may form portions of computer program products. Further, the code can be tangibly stored on one or more volatile or non-volatile tangible computer-readable media, such as during execution or at other times.
- Examples of these tangible computer-readable media can include, but are not limited to, hard disks, removable magnetic disks, removable optical disks (e.g., compact disks and digital video disks), magnetic cassettes, memory cards or sticks, random access memories (RAMs), read only memories (ROMs), and the like.
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Radiology & Medical Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Electromagnetism (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Magnetic Treatment Devices (AREA)
Abstract
Description
in which εcan represent the electromotive force (e.g., in volts), such as developed by a time-varying magnetic flux. The magnetic flux can be represented as
in which B1 can represent an instantaneous magnetic flux density vector (e.g., in Webers per square meter, or Tesla). If B1 is relatively uniform over the surface S, then the magnetic flux can be approximately ΦB1=|B1∥A|, where A can represent the area of the surface S. Operating MRI equipment can produce a time-varying gradient field having a slew rates in excess of 100 Tesla per second (T/s). The slew rate can be similar to a “slope” of the gradient field, and is thus similar to
t fill=(I peak *L)/V +
where Ipeak can represent the specified peak value of the inductor current and V+ can represent a roughly constant battery voltage. For example, when the inductor core saturates, L can be reduced by a factor of about μm, (e.g., the relative magnetic permeability of the core material). In an illustrative example, the following parameters can be used:
-
- L=300 μH
- Ipeak=50 mA
- V+=3 V
- μm=50
In this illustrative example, during normal operation, the fill phase duration can be represented by:
t fill=(I peak *L)/V +=(50 mA)(300 μH)/(3 V)=5 μs
But, in this illustrative example, when the inductor core saturates or when the inductance drops dramatically (e.g., from 300 μH to 6 μH), the fill phase duration can be reduced, and can be represented by:
t fill=(I peak *L)/V +=(50 mA)(6 μH)/(3 V)=100 ns
Thus, in an example, a saturation detection threshold can be tfill<1 μs, and, for example, a core saturation detector can declare a core saturation when tfill<1 μs.
t dump=(I peak *L)/V out
where Ipeak can represent the specified peak value of the inductor current and Voutput can represent a roughly constant battery voltage. In an illustrative example, when the inductor core saturates, L can be reduced, such as by a factor of μm (the relatively magnetic permeability of the core material). In this illustrative example, the following parameters can be used:
-
- L=300 μH
- Ipeak=25 mA
- Voutput=3 V
- μm=50
In this illustrative example, during normal operation, the dump phase duration can be represented by:
t dump=(I peak *L)/V output=(25 mA)(300 μH)/(3 V)=2.5 μs
But, in this illustrative example, when the inductor core saturates or when the inductance drops dramatically (e.g., from 300 μH to 6 μH), the dump phase duration can be reduced, and can be represented by:
t dump=(I peak *L)/V output=(25 mA)(6 μH)/(3 V)=50 ns
Thus, in an example, a saturation detection threshold can be tdump<0.5 μs, and, for example, a core saturation detector can declare a core saturation when tdump<0.5 μs.
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/956,375 US8391992B2 (en) | 2009-12-30 | 2010-11-30 | Implantable medical device switching power supply including multiple modes |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29124309P | 2009-12-30 | 2009-12-30 | |
US12/956,375 US8391992B2 (en) | 2009-12-30 | 2010-11-30 | Implantable medical device switching power supply including multiple modes |
Publications (2)
Publication Number | Publication Date |
---|---|
US20110160806A1 US20110160806A1 (en) | 2011-06-30 |
US8391992B2 true US8391992B2 (en) | 2013-03-05 |
Family
ID=44188443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/956,375 Active 2031-07-07 US8391992B2 (en) | 2009-12-30 | 2010-11-30 | Implantable medical device switching power supply including multiple modes |
Country Status (1)
Country | Link |
---|---|
US (1) | US8391992B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140002085A1 (en) * | 2012-06-28 | 2014-01-02 | Stephan Biber | Automatic Detuning of Non-Connected Transceiver Coils for MRI |
US9586043B2 (en) | 2011-08-31 | 2017-03-07 | Cardiac Pacemakers, Inc. | Remote programming of MRI settings of an implantable medical device |
US10286209B2 (en) | 2016-04-29 | 2019-05-14 | Medtronic, Inc. | Methods and implantable medical devices for automatic entry to an exposure mode of operation upon exposure to a magnetic disturbance |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7509167B2 (en) * | 2006-02-16 | 2009-03-24 | Cardiac Pacemakers, Inc. | MRI detector for implantable medical device |
JP5029914B2 (en) * | 2008-07-31 | 2012-09-19 | アイシン・エィ・ダブリュ株式会社 | Rotating electrical machine control system and vehicle drive system |
KR101686435B1 (en) * | 2010-07-12 | 2016-12-14 | 삼성전자주식회사 | Apparatus and method for reducing electro magnetic interferencefor in portable communication system |
US9533167B2 (en) * | 2011-01-14 | 2017-01-03 | Massachusetts Institute Of Technology | System and method for manipulation of devices using magnetic fields |
US10744320B2 (en) * | 2012-04-27 | 2020-08-18 | Medtronic, Inc. | Magnetic field detector for implantable medical devices |
US20180154146A1 (en) | 2013-05-30 | 2018-06-07 | NeurostimOAB, Inc. | Non-invasive nerve stimulation |
TWI505615B (en) * | 2013-08-19 | 2015-10-21 | Sitronix Technology Corp | Automatic adjustment of the working cycle of the boost circuit |
CN106068141B (en) | 2014-01-10 | 2019-05-14 | 心脏起搏器股份公司 | System and method for detecting cardiac arrhythmia |
JP2017501839A (en) | 2014-01-10 | 2017-01-19 | カーディアック ペースメイカーズ, インコーポレイテッド | Method and system for superior communication between medical devices |
KR102229022B1 (en) * | 2014-03-18 | 2021-03-17 | 삼성전자주식회사 | Device of detecting card having magnetic field monitor and System including the same |
US9457182B2 (en) | 2014-08-26 | 2016-10-04 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with MRI pacing mode |
WO2016033197A2 (en) | 2014-08-28 | 2016-03-03 | Cardiac Pacemakers, Inc. | Medical device with triggered blanking period |
US9669230B2 (en) | 2015-02-06 | 2017-06-06 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
ES2713231T3 (en) | 2015-02-06 | 2019-05-20 | Cardiac Pacemakers Inc | Systems for the safe supply of electrical stimulation therapy |
WO2016130477A2 (en) | 2015-02-09 | 2016-08-18 | Cardiac Pacemakers, Inc. | Implantable medical device with radiopaque id tag |
WO2016141046A1 (en) | 2015-03-04 | 2016-09-09 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
US10050700B2 (en) | 2015-03-18 | 2018-08-14 | Cardiac Pacemakers, Inc. | Communications in a medical device system with temporal optimization |
WO2016149262A1 (en) | 2015-03-18 | 2016-09-22 | Cardiac Pacemakers, Inc. | Communications in a medical device system with link quality assessment |
WO2017007780A1 (en) * | 2015-07-09 | 2017-01-12 | Med-El Elektromedizinische Geraete Gmbh | Telemetry of implanted electrode contacts during mri |
WO2017031221A1 (en) | 2015-08-20 | 2017-02-23 | Cardiac Pacemakers, Inc. | Systems and methods for communication between medical devices |
CN108136187B (en) | 2015-08-20 | 2021-06-29 | 心脏起搏器股份公司 | System and method for communication between medical devices |
US9956414B2 (en) | 2015-08-27 | 2018-05-01 | Cardiac Pacemakers, Inc. | Temporal configuration of a motion sensor in an implantable medical device |
US9968787B2 (en) | 2015-08-27 | 2018-05-15 | Cardiac Pacemakers, Inc. | Spatial configuration of a motion sensor in an implantable medical device |
US10226631B2 (en) | 2015-08-28 | 2019-03-12 | Cardiac Pacemakers, Inc. | Systems and methods for infarct detection |
US10159842B2 (en) | 2015-08-28 | 2018-12-25 | Cardiac Pacemakers, Inc. | System and method for detecting tamponade |
US10137305B2 (en) | 2015-08-28 | 2018-11-27 | Cardiac Pacemakers, Inc. | Systems and methods for behaviorally responsive signal detection and therapy delivery |
WO2017044389A1 (en) | 2015-09-11 | 2017-03-16 | Cardiac Pacemakers, Inc. | Arrhythmia detection and confirmation |
US10065041B2 (en) | 2015-10-08 | 2018-09-04 | Cardiac Pacemakers, Inc. | Devices and methods for adjusting pacing rates in an implantable medical device |
JP6608063B2 (en) | 2015-12-17 | 2019-11-20 | カーディアック ペースメイカーズ, インコーポレイテッド | Implantable medical device |
US10905886B2 (en) | 2015-12-28 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device for deployment across the atrioventricular septum |
US10583303B2 (en) | 2016-01-19 | 2020-03-10 | Cardiac Pacemakers, Inc. | Devices and methods for wirelessly recharging a rechargeable battery of an implantable medical device |
US10350423B2 (en) | 2016-02-04 | 2019-07-16 | Cardiac Pacemakers, Inc. | Delivery system with force sensor for leadless cardiac device |
US11116988B2 (en) | 2016-03-31 | 2021-09-14 | Cardiac Pacemakers, Inc. | Implantable medical device with rechargeable battery |
US10668294B2 (en) | 2016-05-10 | 2020-06-02 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker configured for over the wire delivery |
US10328272B2 (en) | 2016-05-10 | 2019-06-25 | Cardiac Pacemakers, Inc. | Retrievability for implantable medical devices |
CN106110503B (en) * | 2016-06-17 | 2018-11-23 | 清华大学 | A kind of implantable medical devices and its working method with MRI mode |
CN106110504B (en) * | 2016-06-17 | 2019-06-04 | 清华大学 | A kind of implantable medical devices and its working method with MRI mode |
JP6764956B2 (en) | 2016-06-27 | 2020-10-07 | カーディアック ペースメイカーズ, インコーポレイテッド | Cardiac therapy system that uses subcutaneously sensed P-waves for resynchronization pacing management |
US11207527B2 (en) | 2016-07-06 | 2021-12-28 | Cardiac Pacemakers, Inc. | Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
WO2018009392A1 (en) | 2016-07-07 | 2018-01-11 | Cardiac Pacemakers, Inc. | Leadless pacemaker using pressure measurements for pacing capture verification |
WO2018017226A1 (en) | 2016-07-20 | 2018-01-25 | Cardiac Pacemakers, Inc. | System for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
EP3500342B1 (en) | 2016-08-19 | 2020-05-13 | Cardiac Pacemakers, Inc. | Trans-septal implantable medical device |
WO2018039335A1 (en) | 2016-08-24 | 2018-03-01 | Cardiac Pacemakers, Inc. | Integrated multi-device cardiac resynchronization therapy using p-wave to pace timing |
EP3503970B1 (en) | 2016-08-24 | 2023-01-04 | Cardiac Pacemakers, Inc. | Cardiac resynchronization using fusion promotion for timing management |
US10589090B2 (en) * | 2016-09-10 | 2020-03-17 | Boston Scientific Neuromodulation Corporation | Implantable stimulator device with magnetic field sensing circuit |
WO2018057626A1 (en) | 2016-09-21 | 2018-03-29 | Cardiac Pacemakers, Inc. | Implantable cardiac monitor |
US10758737B2 (en) | 2016-09-21 | 2020-09-01 | Cardiac Pacemakers, Inc. | Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter |
US10905889B2 (en) | 2016-09-21 | 2021-02-02 | Cardiac Pacemakers, Inc. | Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery |
US10463305B2 (en) | 2016-10-27 | 2019-11-05 | Cardiac Pacemakers, Inc. | Multi-device cardiac resynchronization therapy with timing enhancements |
US10413733B2 (en) | 2016-10-27 | 2019-09-17 | Cardiac Pacemakers, Inc. | Implantable medical device with gyroscope |
EP3532161B1 (en) | 2016-10-27 | 2023-08-30 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
WO2018081237A1 (en) | 2016-10-27 | 2018-05-03 | Cardiac Pacemakers, Inc. | Use of a separate device in managing the pace pulse energy of a cardiac pacemaker |
WO2018081225A1 (en) | 2016-10-27 | 2018-05-03 | Cardiac Pacemakers, Inc. | Implantable medical device delivery system with integrated sensor |
WO2018081133A1 (en) | 2016-10-27 | 2018-05-03 | Cardiac Pacemakers, Inc. | Implantable medical device having a sense channel with performance adjustment |
CN109890456B (en) | 2016-10-31 | 2023-06-13 | 心脏起搏器股份公司 | System for activity level pacing |
JP6843235B2 (en) | 2016-10-31 | 2021-03-17 | カーディアック ペースメイカーズ, インコーポレイテッド | Systems and methods for activity level pacing |
US10583301B2 (en) | 2016-11-08 | 2020-03-10 | Cardiac Pacemakers, Inc. | Implantable medical device for atrial deployment |
US10632313B2 (en) | 2016-11-09 | 2020-04-28 | Cardiac Pacemakers, Inc. | Systems, devices, and methods for setting cardiac pacing pulse parameters for a cardiac pacing device |
EP3541471B1 (en) | 2016-11-21 | 2021-01-20 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker providing cardiac resynchronization therapy |
US10639486B2 (en) | 2016-11-21 | 2020-05-05 | Cardiac Pacemakers, Inc. | Implantable medical device with recharge coil |
US10881869B2 (en) | 2016-11-21 | 2021-01-05 | Cardiac Pacemakers, Inc. | Wireless re-charge of an implantable medical device |
EP3541473B1 (en) | 2016-11-21 | 2020-11-11 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with multimode communication |
US11147979B2 (en) | 2016-11-21 | 2021-10-19 | Cardiac Pacemakers, Inc. | Implantable medical device with a magnetically permeable housing and an inductive coil disposed about the housing |
US11207532B2 (en) | 2017-01-04 | 2021-12-28 | Cardiac Pacemakers, Inc. | Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system |
WO2018140617A1 (en) | 2017-01-26 | 2018-08-02 | Cardiac Pacemakers, Inc. | Intra-body device communication with redundant message transmission |
WO2018140623A1 (en) | 2017-01-26 | 2018-08-02 | Cardiac Pacemakers, Inc. | Leadless device with overmolded components |
EP3573708B1 (en) | 2017-01-26 | 2021-03-10 | Cardiac Pacemakers, Inc. | Leadless implantable device with detachable fixation |
US10905872B2 (en) | 2017-04-03 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device with a movable electrode biased toward an extended position |
AU2018248361B2 (en) | 2017-04-03 | 2020-08-27 | Cardiac Pacemakers, Inc. | Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate |
EP3668592B1 (en) | 2017-08-18 | 2021-11-17 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
WO2019036568A1 (en) | 2017-08-18 | 2019-02-21 | Cardiac Pacemakers, Inc. | Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator |
JP6938778B2 (en) | 2017-09-20 | 2021-09-22 | カーディアック ペースメイカーズ, インコーポレイテッド | Implantable medical device with multiple modes of operation |
US11986645B2 (en) | 2017-11-07 | 2024-05-21 | Neurostim Technologies Llc | Restless legs syndrome treatment system |
US11185703B2 (en) | 2017-11-07 | 2021-11-30 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker for bundle of his pacing |
EP3706856A4 (en) * | 2017-11-07 | 2021-08-18 | Neurostim Oab, Inc. | Non-invasive nerve activator with adaptive circuit |
WO2019108545A1 (en) | 2017-12-01 | 2019-06-06 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials during ventricular filling from a ventricularly implanted leadless cardiac pacemaker |
EP3717059A1 (en) | 2017-12-01 | 2020-10-07 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker |
CN111417432B (en) | 2017-12-01 | 2024-04-30 | 心脏起搏器股份公司 | Leadless cardiac pacemaker with return behavior |
WO2019108482A1 (en) | 2017-12-01 | 2019-06-06 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker |
US11529523B2 (en) | 2018-01-04 | 2022-12-20 | Cardiac Pacemakers, Inc. | Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone |
WO2019136148A1 (en) | 2018-01-04 | 2019-07-11 | Cardiac Pacemakers, Inc. | Dual chamber pacing without beat-to-beat communication |
EP3768160B1 (en) | 2018-03-23 | 2023-06-07 | Medtronic, Inc. | Vfa cardiac therapy for tachycardia |
CN111902187A (en) | 2018-03-23 | 2020-11-06 | 美敦力公司 | VFA cardiac resynchronization therapy |
CN111886046A (en) | 2018-03-23 | 2020-11-03 | 美敦力公司 | AV-synchronized VFA cardiac therapy |
CN112770807A (en) | 2018-09-26 | 2021-05-07 | 美敦力公司 | Capture in atrial-to-ventricular cardiac therapy |
US11951313B2 (en) | 2018-11-17 | 2024-04-09 | Medtronic, Inc. | VFA delivery systems and methods |
US11679265B2 (en) | 2019-02-14 | 2023-06-20 | Medtronic, Inc. | Lead-in-lead systems and methods for cardiac therapy |
US11697025B2 (en) | 2019-03-29 | 2023-07-11 | Medtronic, Inc. | Cardiac conduction system capture |
US11213676B2 (en) | 2019-04-01 | 2022-01-04 | Medtronic, Inc. | Delivery systems for VfA cardiac therapy |
US11712188B2 (en) | 2019-05-07 | 2023-08-01 | Medtronic, Inc. | Posterior left bundle branch engagement |
US11305127B2 (en) | 2019-08-26 | 2022-04-19 | Medtronic Inc. | VfA delivery and implant region detection |
US11813466B2 (en) | 2020-01-27 | 2023-11-14 | Medtronic, Inc. | Atrioventricular nodal stimulation |
US11911168B2 (en) | 2020-04-03 | 2024-02-27 | Medtronic, Inc. | Cardiac conduction system therapy benefit determination |
US11813464B2 (en) | 2020-07-31 | 2023-11-14 | Medtronic, Inc. | Cardiac conduction system evaluation |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0424574A (en) | 1990-05-19 | 1992-01-28 | Nkk Corp | Detecting device of magnetism |
US5287059A (en) | 1990-05-19 | 1994-02-15 | Nkk Corporation | Saturable core magnetometer with a parallel resonant circuit in which the W3 DC level changes with a change in an external magnetic field |
EP0670170A1 (en) | 1994-02-23 | 1995-09-06 | Pacesetter AB | Combined telemetry and magnetic field detector unit for a medical implant |
EP0718010A1 (en) | 1994-12-15 | 1996-06-26 | Pacesetter AB | Combined telemetry and magnetic field detector unit for a medical implant |
US5552979A (en) * | 1993-11-30 | 1996-09-03 | Philips Electronics North America Corporation | Isolated current sensor for DC to high frequency applications |
US20030144705A1 (en) | 2002-01-29 | 2003-07-31 | Medtronic, Inc. | Methods and apparatus for controlling a pacing system in the presence of EMI |
WO2003063962A1 (en) | 2002-01-29 | 2003-08-07 | Medtronic, Inc. | Magnetic field and/or high frequency radiation signals adaption and control for implantable devices |
US20040052392A1 (en) | 2002-09-16 | 2004-03-18 | Sacha Mike K. | Switching structures for hearing aid |
US20040267233A1 (en) * | 2003-06-30 | 2004-12-30 | Codman Neuro Sciences Sarl | System and method for controlling an implantable medical device subject to magnetic field or radio frequency exposure |
WO2005035048A2 (en) | 2003-09-29 | 2005-04-21 | Medtronic, Inc. | Controlling blanking during magnetic resonance imaging |
US7050855B2 (en) | 2002-01-29 | 2006-05-23 | Medtronic, Inc. | Medical implantable system for reducing magnetic resonance effects |
US20060167496A1 (en) | 2005-01-26 | 2006-07-27 | Nelson Shannon D | System and method for operating an implantable medical device in a disruptive energy field |
WO2006081434A1 (en) | 2005-01-26 | 2006-08-03 | Medtronic, Inc. | Apparatus for detecting strong magnetic fields for protection of medical devices |
US20060293591A1 (en) | 2005-05-12 | 2006-12-28 | Wahlstrand John D | Implantable medical device with MRI and gradient field induced capture detection methods |
US20070191914A1 (en) | 2006-02-16 | 2007-08-16 | Stessman Nicholas J | Mri detector for implantable medical device |
US7369898B1 (en) | 2004-12-22 | 2008-05-06 | Pacesetter, Inc. | System and method for responding to pulsed gradient magnetic fields using an implantable medical device |
US7561915B1 (en) | 2004-12-17 | 2009-07-14 | Cardiac Pacemakers, Inc. | MRI system having implantable device safety features |
US7623930B2 (en) | 2003-09-30 | 2009-11-24 | Medtronic, Inc. | Controlling telemetry during magnetic resonance imaging |
-
2010
- 2010-11-30 US US12/956,375 patent/US8391992B2/en active Active
Patent Citations (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5287059A (en) | 1990-05-19 | 1994-02-15 | Nkk Corporation | Saturable core magnetometer with a parallel resonant circuit in which the W3 DC level changes with a change in an external magnetic field |
JPH0424574A (en) | 1990-05-19 | 1992-01-28 | Nkk Corp | Detecting device of magnetism |
US5552979A (en) * | 1993-11-30 | 1996-09-03 | Philips Electronics North America Corporation | Isolated current sensor for DC to high frequency applications |
EP0670170A1 (en) | 1994-02-23 | 1995-09-06 | Pacesetter AB | Combined telemetry and magnetic field detector unit for a medical implant |
JPH0847543A (en) | 1994-02-23 | 1996-02-20 | Pacesetter Ab | Combination device of telemeter device and magnetic indicator in medical implant equipment |
US5545187A (en) | 1994-02-23 | 1996-08-13 | Pacesetter Ab | Medical field detector and telemetry unit for implants |
JPH08215323A (en) | 1994-12-15 | 1996-08-27 | Pacesetter Ab | Magnetic field detector,implanting type medical treatment apparatus and telemetrymagnetic field detector-bonding unit |
US5662694A (en) | 1994-12-15 | 1997-09-02 | Pacesetter Ab | Magnetic field detector |
EP0718010A1 (en) | 1994-12-15 | 1996-06-26 | Pacesetter AB | Combined telemetry and magnetic field detector unit for a medical implant |
JP2005515857A (en) | 2002-01-29 | 2005-06-02 | メドトロニック・インコーポレーテッド | Implantable medical devices |
US20030144705A1 (en) | 2002-01-29 | 2003-07-31 | Medtronic, Inc. | Methods and apparatus for controlling a pacing system in the presence of EMI |
WO2003063962A1 (en) | 2002-01-29 | 2003-08-07 | Medtronic, Inc. | Magnetic field and/or high frequency radiation signals adaption and control for implantable devices |
US7082328B2 (en) * | 2002-01-29 | 2006-07-25 | Medtronic, Inc. | Methods and apparatus for controlling a pacing system in the presence of EMI |
US7050855B2 (en) | 2002-01-29 | 2006-05-23 | Medtronic, Inc. | Medical implantable system for reducing magnetic resonance effects |
US20040052392A1 (en) | 2002-09-16 | 2004-03-18 | Sacha Mike K. | Switching structures for hearing aid |
US7242981B2 (en) | 2003-06-30 | 2007-07-10 | Codman Neuro Sciences Sárl | System and method for controlling an implantable medical device subject to magnetic field or radio frequency exposure |
JP2005021688A (en) | 2003-06-30 | 2005-01-27 | Codman & Shurtleff Inc | System and method for controlling implantable medical device subject to magnetic field or radio frequency exposure |
US20040267233A1 (en) * | 2003-06-30 | 2004-12-30 | Codman Neuro Sciences Sarl | System and method for controlling an implantable medical device subject to magnetic field or radio frequency exposure |
US7672726B2 (en) | 2003-06-30 | 2010-03-02 | Codman Neuro Sciences Sárl | System and method for controlling an implantable medical device subject to magnetic field or radio frequency exposure |
WO2005035048A2 (en) | 2003-09-29 | 2005-04-21 | Medtronic, Inc. | Controlling blanking during magnetic resonance imaging |
US7623930B2 (en) | 2003-09-30 | 2009-11-24 | Medtronic, Inc. | Controlling telemetry during magnetic resonance imaging |
US7561915B1 (en) | 2004-12-17 | 2009-07-14 | Cardiac Pacemakers, Inc. | MRI system having implantable device safety features |
US7369898B1 (en) | 2004-12-22 | 2008-05-06 | Pacesetter, Inc. | System and method for responding to pulsed gradient magnetic fields using an implantable medical device |
US20060167496A1 (en) | 2005-01-26 | 2006-07-27 | Nelson Shannon D | System and method for operating an implantable medical device in a disruptive energy field |
WO2006081434A1 (en) | 2005-01-26 | 2006-08-03 | Medtronic, Inc. | Apparatus for detecting strong magnetic fields for protection of medical devices |
US20060293591A1 (en) | 2005-05-12 | 2006-12-28 | Wahlstrand John D | Implantable medical device with MRI and gradient field induced capture detection methods |
US20070191914A1 (en) | 2006-02-16 | 2007-08-16 | Stessman Nicholas J | Mri detector for implantable medical device |
US20090182389A1 (en) | 2006-02-16 | 2009-07-16 | Stessman Nicholas J | Mri detector for implantable medical device |
US7509167B2 (en) | 2006-02-16 | 2009-03-24 | Cardiac Pacemakers, Inc. | MRI detector for implantable medical device |
WO2007094976A1 (en) | 2006-02-16 | 2007-08-23 | Cardiac Pacemakers, Inc. | Mri detector for implantable medical device |
Non-Patent Citations (20)
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9586043B2 (en) | 2011-08-31 | 2017-03-07 | Cardiac Pacemakers, Inc. | Remote programming of MRI settings of an implantable medical device |
US9827417B2 (en) | 2011-08-31 | 2017-11-28 | Cardiac Pacemakers, Inc. | Remote programming of MRI settings of an implantable medical device |
US20140002085A1 (en) * | 2012-06-28 | 2014-01-02 | Stephan Biber | Automatic Detuning of Non-Connected Transceiver Coils for MRI |
US10114091B2 (en) * | 2012-06-28 | 2018-10-30 | Siemens Aktiengesellschaft | Automatic detuning of non-connected transceiver coils for MRI |
US10286209B2 (en) | 2016-04-29 | 2019-05-14 | Medtronic, Inc. | Methods and implantable medical devices for automatic entry to an exposure mode of operation upon exposure to a magnetic disturbance |
US11628298B2 (en) | 2016-04-29 | 2023-04-18 | Medtronic, Inc. | Methods and implantable medical devices for automatic entry to an exposure mode of operation upon exposure to a magnetic disturbance |
Also Published As
Publication number | Publication date |
---|---|
US20110160806A1 (en) | 2011-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8391992B2 (en) | Implantable medical device switching power supply including multiple modes | |
JP5079711B2 (en) | Implantable medical device with MRI detector | |
US20110160565A1 (en) | Detecting proximity to mri scanner | |
US20210123994A1 (en) | Systems and methods for sensing external magnetic fields in implantable medical devices | |
US8958877B2 (en) | Implantable device with bias for MRI | |
Arfin et al. | An energy-efficient, adiabatic electrode stimulator with inductive energy recycling and feedback current regulation | |
EP2849842B1 (en) | Pulse-by-pulse compliance voltage generation for an implantable stimulator | |
EP3484579B1 (en) | Implantable stimulator device with magnetic field sensing circuit | |
US8538550B2 (en) | Implantable device failsafe mode for MRI | |
CA2469159A1 (en) | Control of arbitrary waveforms for constant delivered energy | |
US9603549B2 (en) | Implantable device with post-MRI cardiac signal sensing adjustment | |
US8710841B2 (en) | Sensing during magnetic resonance imaging | |
US8855784B2 (en) | Implantable medical device including controllably isolated housing | |
CN105896984B (en) | Boost circuit and DC-DC module, stimulation circuit and implantable medical devices | |
US8380302B2 (en) | Implantable medical device including eddy current reducing capacitor | |
CN107715300A (en) | A kind of implantable medical devices with MRI patterns | |
Toyoshima | Reconsideration of EMI phenomenon in active implantable medical devices in the age of MR Conditional devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CARDIAC PACEMAKERS, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LYDEN, MICHAEL J.;STESSMAN, NICHOLAS J.;SIGNING DATES FROM 20101117 TO 20101122;REEL/FRAME:025592/0937 |
|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1552); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 8 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 12 |